Key stats
Market capitalization
108.848MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
About BriaCell Therapeutics Corp
ISIN
CA10778Y3023
Sector
Health Technology
Industry
Biotechnology
Website
briacell.com
CEO
William V. Williams
Headquarters
West Vancouver
Employees
8
Founded
2006
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0